ArticlebioRxiv : the preprint server for biology2026
VDJdive and ECLIPSE enhance single-cell TCR sequencing analysis through the probabilistic resolution of ambiguous clonotypes.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Single-cell T cell receptor sequencing (scTCR-seq) has transformed our ability to track individual T cell clones and has been instrumental in advancing our understanding of human T cell differentiation. However, current computational pipelines for analysis, which require precise matching of CDR3 sequences from exactly 2 heterodimeric TCR chains to define the clonotype for each cell, are inherently limited because of the substantial proportion of cells possessing "ambiguous" clonotypes driven by missing (undetected from the technical issue of chain "dropout") or extra chains (present from either true biological expression or due to technical artifacts such as cellular doublets and ambient TCR contamination). As a result, clone sizes are artificially reduced, impeding the tracking of clones across conditions and differentiation states. Here we introduce VDJdive and ECLIPSE (Enhanced CLonotypic Inference via Prediction of Single-cell Expression), two computational methods that, together, resolve this clonal ambiguity by utilizing the expectation-maximization algorithm for the clonal prediction of ambiguous cells. These methods consider chain pairings across the sample, allowing for high-fidelity prediction of chains lost due to dropout and the discernment of biological expression of extra chains from technical artifacts. Consequently, clone sizes are augmented and cells without clonotype assignments are minimized. Our approach facilitates enhanced clonal tracking through these elevated clone sizes and is easily implementable, compatible with standard single-cell transcriptomic workflows, and broadly applicable across biological contexts and T cell subsets.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.